Literature DB >> 19454667

Phenotypic and functional analyses of KIR3DL1+ and KIR3DS1+ NK cell subsets demonstrate differential regulation by Bw4 molecules and induced KIR3DS1 expression on stimulated NK cells.

Maelig Morvan1, Catherine Willem, Katia Gagne, Nolwenn Kerdudou, Gaelle David, Véronique Sébille, Gilles Folléa, Jean-Denis Bignon, Christelle Retière.   

Abstract

Recently, the Z27 mAb was shown to recognize the NK cell-activating receptor KIR3DS1, and several genetic studies suggest that the most probable ligands of KIR3DS1 are HLA class I molecules with the Bw4 motif. Despite these findings, the attempts to establish a functional interaction between KIR3DS1 and its potential ligand have been unsuccessful. Here, we study the proliferation and cytotoxicity of KIR3DS1(+) NK cells, compared with KIR3DL1(+) NK cells, according to the Bw4(+) or Bw4(-) allogeneic environment. Our results show for the first time that KIR3DS1 expression on NK cells can be induced after exposure to stimulator cells (221, K562, EBV-B cell lines, and B cells), polyinosinic-polycytidylic acid, IL-15, or IL-2. Furthermore, whereas KIR3DL1(+) NK cell proliferation and cytotoxicity were inhibited in a Bw4(+) but not a Bw4(-) context, KIR3DS1(+) NK cell functions were not influenced by the presence of Bw4 on target cells. Nevertheless, despite the absence of demonstrated regulation of KIR3DS1(+) NK cell functions by HLA-Bw4 molecules, we found a higher KIR3DS1(+) NK cell frequency and higher levels of KIR3DS1 expression in Bw4(+) compared with Bw4(-) individuals. Altogether, these results suggest that KIR3DS1 does not recognize HLA-Bw4 molecules in a physiological context, and they highlight the induced expression of KIR3DS1 observed on stimulated NK cells and the higher frequency of KIR3DS1(+) NK cells in Bw4(+) individuals. Because a protective KIR3DS1-Bw4 association has been reported in viral infections, our results further the understanding of the role of KIR3DS1(+) NK cells in controlling viral infections.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19454667     DOI: 10.4049/jimmunol.0900212

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  14 in total

1.  Association of KIR3DL1/S1 and HLA-Bw4 with CD4 T cell counts in HIV-infected Mexican mestizos.

Authors:  Daniel Hernández-Ramírez; Mario A Esparza-Pérez; José L Ramirez-Garcialuna; J Rafael Arguello; Peter B Mandeville; Daniel E Noyola; Christian A García-Sepúlveda
Journal:  Immunogenetics       Date:  2015-06-03       Impact factor: 2.846

2.  Interactions of NK cell receptor KIR3DL1*004 with chaperones and conformation-specific antibody reveal a functional folded state as well as predominant intracellular retention.

Authors:  Sabrina B Taner; Marcelo J Pando; Allison Roberts; Jennifer Schellekens; Steven G E Marsh; Karl-Johan Malmberg; Peter Parham; Frances M Brodsky
Journal:  J Immunol       Date:  2010-11-29       Impact factor: 5.422

3.  Dimorphic motifs in D0 and D1+D2 domains of killer cell Ig-like receptor 3DL1 combine to form receptors with high, moderate, and no avidity for the complex of a peptide derived from HIV and HLA-A*2402.

Authors:  Deepti Sharma; Karine Bastard; Lisbeth A Guethlein; Paul J Norman; Nobuyo Yawata; Makoto Yawata; Marcelo Pando; Hathairat Thananchai; Tao Dong; Sarah Rowland-Jones; Frances M Brodsky; Peter Parham
Journal:  J Immunol       Date:  2009-09-14       Impact factor: 5.422

4.  KIR-HLA-A and B alleles of the Bw4 epitope against HIV infection in discordant heterosexual couples in Chaco Argentina.

Authors:  Alicia Habegger de Sorrentino; Jessica L Sinchi; Karina Marinic; Rosana López; Ernesto Iliovich
Journal:  Immunology       Date:  2013-10       Impact factor: 7.397

5.  The antiviral factor APOBEC3G enhances the recognition of HIV-infected primary T cells by natural killer cells.

Authors:  Jason M Norman; Michael Mashiba; Lucy A McNamara; Adewunmi Onafuwa-Nuga; Estelle Chiari-Fort; Wenwen Shen; Kathleen L Collins
Journal:  Nat Immunol       Date:  2011-08-28       Impact factor: 25.606

6.  Low CD4+ T cell counts among African HIV-1 infected subjects with group B KIR haplotypes in the absence of specific inhibitory KIR ligands.

Authors:  Wim Jennes; Sonja Verheyden; Christian Demanet; Joris Menten; Bea Vuylsteke; John N Nkengasong; Luc Kestens
Journal:  PLoS One       Date:  2011-02-14       Impact factor: 3.240

7.  Influence of HLA-C environment on the spontaneous clearance of hepatitis C in European HIV-HCV co-infected individuals.

Authors:  N Legrand; G David; C Retière; C Allavena; A Rodallec; A Gaultier; D Salmon; A Cesbron; L Wittkop; F Raffi; K Gendzekhadze; K Gagne
Journal:  Clin Exp Immunol       Date:  2021-02-02       Impact factor: 5.732

8.  Natural killer cells in patients with severe chronic fatigue syndrome.

Authors:  E W Brenu; S L Hardcastle; G M Atkinson; M L van Driel; S Kreijkamp-Kaspers; K J Ashton; D R Staines; S M Marshall-Gradisnik
Journal:  Auto Immun Highlights       Date:  2013-04-16

Review 9.  Activating killer cell Ig-like receptors in health and disease.

Authors:  Martin A Ivarsson; Jakob Michaëlsson; Cyril Fauriat
Journal:  Front Immunol       Date:  2014-04-22       Impact factor: 7.561

10.  Role of KIR3DS1 in human diseases.

Authors:  Christian Körner; Marcus Altfeld
Journal:  Front Immunol       Date:  2012-11-01       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.